Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kornek

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 12, 2013
Skin cancer preventionThomas Kornek, Matthias Augustin
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2011
Skin cancer screening in Germany - perception by the publicMatthias Augustin, Rudolf Stadler, Michael Reusch, et al.
Dermatology (Basel, Switzerland)|January 9, 2013
Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspectiveThomas Kornek, Ines Schäfer, Michael Reusch, et al.
Medicine|November 19, 2016
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapyKatharina C Kaehler, Christine Blome, Andrea Forschner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 12, 2013
Skin cancer preventionThomas Kornek, Matthias Augustin
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2011
Skin cancer screening in Germany - perception by the publicMatthias Augustin, Rudolf Stadler, Michael Reusch, et al.
Dermatology (Basel, Switzerland)|January 9, 2013
Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspectiveThomas Kornek, Ines Schäfer, Michael Reusch, et al.
Medicine|November 19, 2016
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapyKatharina C Kaehler, Christine Blome, Andrea Forschner, et al.
Pageof 1